サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1492338

ポリメラーゼ連鎖反応市場：世界の産業分析、規模、シェア、成長、動向、2024-2032年予測

Polymerase Chain Reaction Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2024-2032

出版日
ページ情報
英文 250 Pages
納期
2～5営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=144.06円
ポリメラーゼ連鎖反応市場：世界の産業分析、規模、シェア、成長、動向、2024-2032年予測
出版日: 2024年06月04日
発行: Persistence Market Research
ページ情報: 英文 250 Pages
納期: 2～5営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

この調査レポートは世界のポリメラーゼ連鎖反応（PCR）市場を詳細に分析しています。この包括的なレポートは、主要な市場力学、成長促進要因、課題、新興動向に関する貴重な洞察を提供します。PCR産業の詳細な概観を提供し、2024年から2032年までの市場成長軌道を予測する独占データと統計を提示しています。

主な洞察

  • PCR市場規模（2024年）：255億米ドル
  • 予測市場価値（2032年）：297億米ドル
  • 世界市場成長率（CAGR 2024年～2032年）：1.9%

PCR市場- 調査範囲：

ポリメラーゼ連鎖反応（PCR）市場は、正確で効率的なDNA増幅と分析に対するヘルスケア、バイオテクノロジー、法医学分野からの需要の増加に牽引され、力強い成長を遂げています。この市場は、学術・研究機関、病院、診断研究所、製薬・バイオテクノロジー企業、法医学研究所にサービスを提供し、様々な用途のPCR装置、試薬、ソフトウェアソリューションを提供しています。PCRは遺伝子研究、臨床診断、疾病検出、医薬品開発、法医学分析において重要な役割を果たしており、高精度と高感度で特定のDNA配列を増幅することができます。市場成長の原動力は、PCR技術の進歩、感染症や遺伝性疾患の有病率の上昇、臨床や研究現場でのPCR採用の増加です。

市場促進要因：

世界のPCR市場はいくつかの主要な成長促進要因の恩恵を受けています。COVID-19を含む感染症の罹患率の増加は、正確かつ迅速な病原体検出のためのPCRベースの診断テストへの需要を促進します。さらに、デジタルPCR、リアルタイムPCR（qPCR）、マルチプレックスPCRなどのPCR技術の進歩は、ハイスループット、定量的、複数のターゲットの同時分析を可能にし、診断および研究能力を向上させる。さらに、個別化医療と分子診断への注目の高まりは、遺伝子検査、腫瘍学、薬理ゲノミクスにおけるPCRの採用を促進し、市場拡大を後押ししています。ライフサイエンス研究への投資の増加は、ヘルスケアインフラと疾病監視を強化する政府のイニシアティブと相まって、市場の成長をさらに後押ししています。

市場抑制要因：

有望な成長見通しにもかかわらず、PCR市場はコスト、技術的複雑さ、規制遵守に関する課題に直面しています。PCR装置や試薬のコストが高いため、特に資源に乏しい環境や新興市場では導入が制限される可能性があります。さらに、プライマー設計、増幅効率、汚染リスクなどの技術的課題は、PCR結果の正確性と信頼性に影響を与える可能性があり、専門的な知識と厳格な品質管理対策を必要とします。さらに、臨床・診断用途の規制要件や国際規格への準拠は市場参入企業に課題をもたらし、製品開拓、承認、商品化のタイムラインに影響を与えます。これらの障壁に対処するには、製品の性能を高め、コストを削減し、規制基準への適合を確実にするための研究開発、トレーニング、品質保証への投資が必要です。

市場機会：

PCR市場は、技術革新、市場の多様化、アプリケーションの拡大により大きな成長機会をもたらします。ナノポアシークエンシング、マイクロフルイディクス、ラボオンチップデバイスなどの次世代PCR技術の開発は、PCRワークフローの小型化、自動化、統合を可能にし、スループット、感度、使いやすさを向上させる。さらに、ポイントオブケア（POC）診断と迅速検査ソリューションに対する需要の高まりは、遠隔地や資源が限られた環境での分散型検査の必要性に対応し、ポータブルで現場展開可能なPCRシステムの機会を創出します。さらに、戦略的パートナーシップ、合併、買収は、市場参入、製品の多様化、地域拡大を促進し、企業が世界のPCRランドスケープにおける新たな動向と市場機会を活用することを可能にします。

目次

第1章 エグゼクティブサマリー

第2章 市場概要

  • 市場範囲/ 分類
  • 市場の定義/ 範囲/ 制限

第3章 市場背景

  • 市場力学
  • シナリオ予測
  • 機会マップ分析
  • 投資実現可能性マトリックス
  • PESTLEとポーター分析
  • 規制状況

第4章 世界のポリメラーゼ連鎖反応市場分析

  • 過去の市場規模（金額）分析、2019年～2023年
  • 現在および将来の市場規模（金額）予測、2024～2032年
    • 前年比成長動向分析
    • 絶対的収益機会分析

第5章 世界のポリメラーゼ連鎖反応市場分析：タイプ別

  • イントロダクション/主な調査結果
  • 過去の市場規模（金額）分析、2019年～2023年
  • 現在および将来の市場規模（金額）分析と予測、2024～2032年
    • 従来のPCR
    • その他のタイプ
  • 前年比成長動向分析、2019～2023年
  • 絶対的収益機会分析、2024～2032年

第6章 世界のポリメラーゼ連鎖反応市場分析：製品タイプ別

  • イントロダクション/主な調査結果
  • 過去の市場規模（金額）分析、2019年～2023年
  • 現在および将来の市場規模（金額）分析と予測、2024～2032年
    • 消耗品と試薬
    • 機器
    • ソフトウェアとサービス
  • 前年比成長動向分析、2019～2023年
  • 絶対的収益機会分析、2024～2032年

第7章 世界のポリメラーゼ連鎖反応市場分析：用途別

  • イントロダクション/主な調査結果
  • 過去の市場規模（金額）分析、2019年～2023年
  • 現在および将来の市場規模（金額）分析と予測、2024～2032年
    • 医療
      • 臨床
      • 研究
      • 法医学・その他
    • 非医療
      • 食品
      • その他の非医療
  • 前年比成長動向分析、2019～2023年
  • 絶対的収益機会分析、2024～2032年

第8章 ポリメラーゼ連鎖反応市場分析：地域別

  • イントロダクション
  • 過去の市場規模（金額）分析、2019年～2023年
  • 現在の市場規模（金額）分析と予測、2024～2032年
    • 北米
    • ラテンアメリカ
    • 欧州
    • 東アジア
    • 南アジア
    • オセアニア
    • 中東・アフリカ
  • 地域別市場の魅力分析

第9章 北米のポリメラーゼ連鎖反応市場分析（国別）

第10章 ラテンアメリカのポリメラーゼ連鎖反応市場分析（国別）

第11章 欧州のポリメラーゼ連鎖反応市場分析（国別）

第12章 東アジアのポリメラーゼ連鎖反応市場分析（国別）

第13章 南アジアのポリメラーゼ連鎖反応市場分析（国別）

第14章 オセアニアのポリメラーゼ連鎖反応市場分析（国別）

第15章 中東・アフリカポリメラーゼ連鎖反応市場分析（国別）

第16章 主要国のポリメラーゼ連鎖反応市場分析

  • 米国
  • カナダ
  • ブラジル
  • メキシコ
  • アルゼンチン
  • ドイツ
  • イタリア
  • フランス
  • 英国
  • スペイン
  • ロシア
  • ベネルクス
  • 中国
  • 日本
  • 韓国
  • インド
  • タイ
  • マレーシア
  • インドネシア
  • オーストラリア
  • ニュージーランド
  • GCC諸国

第17章 市場構造分析

  • 競合ダッシュボード
  • 競合ベンチマーク
  • 主要企業の市場シェア分析

第18章 競合分析

  • 競合の詳細
    • Abbott
    • Thermo Fisher Scientific Inc.
    • F. Hoffmann-La Roche Ltd.
    • Bio-Rad Laboratories Inc.
    • QIAGEN NV
    • bioMerieux SA
    • Standard BioTools Inc.
    • Sysmex Inostics
    • Eppendorf AG
    • Danaher Corporation
    • Cytiva
    • Stilla Technologies
    • Microsynth AG
    • MatMaCorp
    • JN Medsys
    • PCR Biosystems

第19章 使用される前提条件と頭字語

第20章 調査手法

目次
Product Code: PMRREP33241

Persistence Market Research, a leading market research firm, has conducted an in-depth analysis of the global Polymerase Chain Reaction (PCR) Market. This comprehensive report provides valuable insights into key market dynamics, growth drivers, challenges, and emerging trends. It offers a detailed overview of the PCR industry, presenting exclusive data and statistics projecting the market's growth trajectory from 2024 to 2032.

Key Insights:

  • PCR Market Size (2024): US$ 25.5 Bn
  • Projected Market Value (2032): US$ 29.7 Bn
  • Global Market Growth Rate (CAGR 2024 to 2032): 1.9%

PCR Market - Report Scope:

The Polymerase Chain Reaction (PCR) Market is experiencing robust growth, driven by increasing demand from the healthcare, biotechnology, and forensic science sectors for precise and efficient DNA amplification and analysis. This market serves academic and research institutions, hospitals and diagnostic laboratories, pharmaceutical and biotechnology companies, and forensic laboratories, offering a range of PCR instruments, reagents, and software solutions for various applications. PCR plays a critical role in genetic research, clinical diagnostics, disease detection, drug development, and forensic analysis, enabling the amplification of specific DNA sequences with high accuracy and sensitivity. Market growth is fueled by advancements in PCR technology, rising prevalence of infectious diseases and genetic disorders, and increasing adoption of PCR in clinical and research settings.

Market Growth Drivers:

The global PCR Market benefits from several key growth drivers. The rising incidence of infectious diseases, including COVID-19, drives demand for PCR-based diagnostic tests for accurate and rapid pathogen detection. Additionally, advancements in PCR technology, such as digital PCR, real-time PCR (qPCR), and multiplex PCR, enable high-throughput, quantitative, and simultaneous analysis of multiple targets, enhancing diagnostic and research capabilities. Moreover, the increasing focus on personalized medicine and molecular diagnostics fuels the adoption of PCR in genetic testing, oncology, and pharmacogenomics, driving market expansion. The growing investment in life sciences research, coupled with government initiatives to enhance healthcare infrastructure and disease surveillance, further supports market growth.

Market Restraints:

Despite its promising growth prospects, the PCR Market faces challenges related to cost, technical complexities, and regulatory compliance. The high cost of PCR instruments and reagents may limit adoption, particularly in resource-constrained settings and emerging markets. Additionally, technical challenges, such as primer design, amplification efficiency, and contamination risks, may impact the accuracy and reliability of PCR results, requiring specialized expertise and stringent quality control measures. Furthermore, regulatory requirements and compliance with international standards for clinical and diagnostic applications pose challenges for market participants, impacting product development, approval, and commercialization timelines. Addressing these barriers requires investment in research and development, training, and quality assurance to enhance product performance, reduce costs, and ensure compliance with regulatory standards.

Market Opportunities:

The PCR Market presents significant growth opportunities driven by technological innovations, market diversification, and application expansion. The development of next-generation PCR technologies, such as nanopore sequencing, microfluidics, and lab-on-a-chip devices, enables miniaturization, automation, and integration of PCR workflows, enhancing throughput, sensitivity, and ease of use. Moreover, the growing demand for point-of-care (POC) diagnostics and rapid testing solutions creates opportunities for portable and field-deployable PCR systems, addressing the need for decentralized testing in remote and resource-limited settings. Furthermore, strategic partnerships, mergers, and acquisitions facilitate market entry, product diversification, and geographic expansion, enabling companies to capitalize on emerging trends and market opportunities in the global PCR landscape.

Competitive Intelligence and Business Strategy:

Leading players in the global PCR Market, including [Insert Key Companies], focus on innovation, product differentiation, and market expansion to gain a competitive edge. These companies invest in research and development to develop next-generation PCR instruments, reagents, and software solutions, explore new applications and markets, and enhance product performance and user experience. Collaborations with academic and research institutions, diagnostic laboratories, and biotechnology companies enable companies to gain insights into market trends, customer needs, and regulatory developments, driving product innovation and market adoption. Moreover, emphasis on quality assurance, supply chain management, and customer support enhances brand reputation and customer trust in the competitive landscape of PCR technologies and solutions.

Key Companies Profiled:

  • Abbott
  • Thermo Fisher Scientific Inc.
  • F. Hoffmann- La Roche Ltd.
  • Bio-Rad Laboratories Inc.
  • QIAGEN N.V.
  • bioMerieux SA
  • Standard BioTools Inc.
  • Sysmex Inostics
  • Eppendorf AG
  • Danaher Corporation
  • Cytiva
  • Stilla Technologies
  • Microsynth AG
  • MatMaCorp
  • JN Medsys
  • PCR Biosystems

PCR Market Research Segmentation:

By Type

  • Conventional PCR
  • Other Types

By Product Type

  • Consumables & Reagents
  • Instruments
  • Software & Services

By Application

  • Medical
  • Clinical
  • Research
  • Forensic and others
  • Non-Medical
  • Food
  • Other Non-Medicals

By Region

  • North America
  • The US
  • Canada
  • The Asia Pacific
  • China
  • Japan
  • South Korea
  • India
  • Europe
  • Germany
  • UK
  • France
  • Russia
  • Italy
  • The Middle East and Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Nigeria
  • Egypt
  • Latin America
  • Mexico
  • Brazil
  • Argentina
  • Colombia

Table of Contents

1. Executive Summary

  • 1.1. Global Market Outlook
  • 1.2. Demand-side Trends
  • 1.3. Supply-side Trends
  • 1.4. Technology Roadmap Analysis
  • 1.5. Analysis and Recommendations

2. Market Overview

  • 2.1. Market Coverage / Taxonomy
  • 2.2. Market Definition / Scope / Limitations

3. Market Background

  • 3.1. Market Dynamics
    • 3.1.1. Drivers
    • 3.1.2. Restraints
    • 3.1.3. Opportunity
    • 3.1.4. Trends
  • 3.2. Scenario Forecast
    • 3.2.1. Demand in Optimistic Scenario
    • 3.2.2. Demand in Likely Scenario
    • 3.2.3. Demand in Conservative Scenario
  • 3.3. Opportunity Map Analysis
  • 3.4. Investment Feasibility Matrix
  • 3.5. PESTLE and Porter's Analysis
  • 3.6. Regulatory Landscape
    • 3.6.1. By Key Regions
    • 3.6.2. By Key Countries

4. Global Polymerase Chain Reaction Market Analysis 2019-2023 and Forecast, 2024-2032

  • 4.1. Historical Market Size Value (US$ Bn) Analysis, 2019-2023
  • 4.2. Current and Future Market Size Value (US$ Bn) Projections, 2024-2032
    • 4.2.1. Y-o-Y Growth Trend Analysis
    • 4.2.2. Absolute $ Opportunity Analysis

5. Global Polymerase Chain Reaction Market Analysis 2019-2023 and Forecast 2024-2032, By Type

  • 5.1. Introduction / Key Findings
  • 5.2. Historical Market Size Value (US$ Bn) Analysis By Type, 2019-2023
  • 5.3. Current and Future Market Size Value (US$ Bn) Analysis and Forecast By Type, 2024-2032
    • 5.3.1. Conventional PCR
    • 5.3.2. Other Types
  • 5.4. Y-o-Y Growth Trend Analysis By Type, 2019-2023
  • 5.5. Absolute $ Opportunity Analysis By Type, 2024-2032

6. Global Polymerase Chain Reaction Market Analysis 2019-2023 and Forecast 2024-2032, By Product Type

  • 6.1. Introduction / Key Findings
  • 6.2. Historical Market Size Value (US$ Bn) Analysis By Product Type, 2019-2023
  • 6.3. Current and Future Market Size Value (US$ Bn) Analysis and Forecast By Product Type, 2024-2032
    • 6.3.1. Consumables & Reagents
    • 6.3.2. Instruments
    • 6.3.3. Software & Services
  • 6.4. Y-o-Y Growth Trend Analysis By Product Type, 2019-2023
  • 6.5. Absolute $ Opportunity Analysis By Product Type, 2024-2032

7. Global Polymerase Chain Reaction Market Analysis 2019-2023 and Forecast 2024-2032, By Application

  • 7.1. Introduction / Key Findings
  • 7.2. Historical Market Size Value (US$ Bn) Analysis By Application, 2019-2023
  • 7.3. Current and Future Market Size Value (US$ Bn) Analysis and Forecast By Application, 2024-2032
    • 7.3.1. Medical
      • 7.3.1.1. Clinical
      • 7.3.1.2. Research
      • 7.3.1.3. Forensic and others
    • 7.3.2. Non-Medical
      • 7.3.2.1. Food
      • 7.3.2.2. Other Non-Medicals
  • 7.4. Y-o-Y Growth Trend Analysis By Application, 2019-2023
  • 7.5. Absolute $ Opportunity Analysis By Application, 2024-2032

8. Global Polymerase Chain Reaction Market Analysis 2019-2023 and Forecast 2024-2032, By Region

  • 8.1. Introduction
  • 8.2. Historical Market Size Value (US$ Bn) Analysis By Region, 2019-2023
  • 8.3. Current Market Size Value (US$ Bn) Analysis and Forecast By Region, 2024-2032
    • 8.3.1. North America
    • 8.3.2. Latin America
    • 8.3.3. Europe
    • 8.3.4. East Asia
    • 8.3.5. South Asia
    • 8.3.6. Oceania
    • 8.3.7. MEA
  • 8.4. Market Attractiveness Analysis By Region

9. North America Polymerase Chain Reaction Market Analysis 2019-2023 and Forecast 2024-2032, By Country

  • 9.1. Historical Market Size Value (US$ Bn) Trend Analysis By Market Taxonomy, 2019-2023
  • 9.2. Market Size Value (US$ Bn) Forecast By Market Taxonomy, 2024-2032
    • 9.2.1. By Country
      • 9.2.1.1. U.S.
      • 9.2.1.2. Canada
    • 9.2.2. By Type
    • 9.2.3. By Product Type
    • 9.2.4. By Application
  • 9.3. Market Attractiveness Analysis
    • 9.3.1. By Country
    • 9.3.2. By Type
    • 9.3.3. By Product Type
    • 9.3.4. By Application
  • 9.4. Key Takeaways

10. Latin America Polymerase Chain Reaction Market Analysis 2019-2023 and Forecast 2024-2032, By Country

  • 10.1. Historical Market Size Value (US$ Bn) Trend Analysis By Market Taxonomy, 2019-2023
  • 10.2. Market Size Value (US$ Bn) Forecast By Market Taxonomy, 2024-2032
    • 10.2.1. By Country
      • 10.2.1.1. Brazil
      • 10.2.1.2. Mexico
      • 10.2.1.3. Argentina
      • 10.2.1.4. Rest of Latin America
    • 10.2.2. By Type
    • 10.2.3. By Product Type
    • 10.2.4. By Application
  • 10.3. Market Attractiveness Analysis
    • 10.3.1. By Country
    • 10.3.2. By Type
    • 10.3.3. By Product Type
    • 10.3.4. By Application
  • 10.4. Key Takeaways

11. Europe Polymerase Chain Reaction Market Analysis 2019-2023 and Forecast 2024-2032, By Country

  • 11.1. Historical Market Size Value (US$ Bn) Trend Analysis By Market Taxonomy, 2019-2023
  • 11.2. Market Size Value (US$ Bn) Forecast By Market Taxonomy, 2024-2032
    • 11.2.1. By Country
      • 11.2.1.1. Germany
      • 11.2.1.2. Italy
      • 11.2.1.3. France
      • 11.2.1.4. U.K.
      • 11.2.1.5. Spain
      • 11.2.1.6. Russia
      • 11.2.1.7. BENELUX
      • 11.2.1.8. Rest of Europe
    • 11.2.2. By Type
    • 11.2.3. By Product Type
    • 11.2.4. By Application
  • 11.3. Market Attractiveness Analysis
    • 11.3.1. By Country
    • 11.3.2. By Type
    • 11.3.3. By Product Type
    • 11.3.4. By Application
  • 11.4. Key Takeaways

12. East Asia Polymerase Chain Reaction Market Analysis 2019-2023 and Forecast 2024-2032, By Country

  • 12.1. Historical Market Size Value (US$ Bn) Trend Analysis By Market Taxonomy, 2019-2023
  • 12.2. Market Size Value (US$ Bn) Forecast By Market Taxonomy, 2024-2032
    • 12.2.1. By Country
      • 12.2.1.1. China
      • 12.2.1.2. Japan
      • 12.2.1.3. South Korea
    • 12.2.2. By Type
    • 12.2.3. By Product Type
    • 12.2.4. By Application
  • 12.3. Market Attractiveness Analysis
    • 12.3.1. By Country
    • 12.3.2. By Type
    • 12.3.3. By Product Type
    • 12.3.4. By Application
  • 12.4. Key Takeaways

13. South Asia Polymerase Chain Reaction Market Analysis 2019-2023 and Forecast 2024-2032, By Country

  • 13.1. Historical Market Size Value (US$ Bn) Trend Analysis By Market Taxonomy, 2019-2023
  • 13.2. Market Size Value (US$ Bn) Forecast By Market Taxonomy, 2024-2032
    • 13.2.1. By Country
      • 13.2.1.1. India
      • 13.2.1.2. Thailand
      • 13.2.1.3. Malaysia
      • 13.2.1.4. Indonesia
      • 13.2.1.5. Rest of South Asia
    • 13.2.2. By Type
    • 13.2.3. By Product Type
    • 13.2.4. By Application
  • 13.3. Market Attractiveness Analysis
    • 13.3.1. By Country
    • 13.3.2. By Type
    • 13.3.3. By Product Type
    • 13.3.4. By Application
  • 13.4. Key Takeaways

14. Oceania Polymerase Chain Reaction Market Analysis 2019-2023 and Forecast 2024-2032, By Country

  • 14.1. Historical Market Size Value (US$ Bn) Trend Analysis By Market Taxonomy, 2019-2023
  • 14.2. Market Size Value (US$ Bn) Forecast By Market Taxonomy, 2024-2032
    • 14.2.1. By Country
      • 14.2.1.1. Australia
      • 14.2.1.2. New Zealand
    • 14.2.2. By Type
    • 14.2.3. By Product Type
    • 14.2.4. By Application
  • 14.3. Market Attractiveness Analysis
    • 14.3.1. By Country
    • 14.3.2. By Type
    • 14.3.3. By Product Type
    • 14.3.4. By Application
  • 14.4. Key Takeaways

15. MEA Polymerase Chain Reaction Market Analysis 2019-2023 and Forecast 2024-2032, By Country

  • 15.1. Historical Market Size Value (US$ Bn) Trend Analysis By Market Taxonomy, 2019-2023
  • 15.2. Market Size Value (US$ Bn) Forecast By Market Taxonomy, 2024-2032
    • 15.2.1. By Country
      • 15.2.1.1. GCC
      • 15.2.1.2. Rest of MEA
    • 15.2.2. By Type
    • 15.2.3. By Product Type
    • 15.2.4. By Application
  • 15.3. Market Attractiveness Analysis
    • 15.3.1. By Country
    • 15.3.2. By Type
    • 15.3.3. By Product Type
    • 15.3.4. By Application
  • 15.4. Key Takeaways

16. Key Countries Polymerase Chain Reaction Market Analysis

  • 16.1. U.S.
    • 16.1.1. Pricing Analysis
    • 16.1.2. Market Share Analysis, 2023
      • 16.1.2.1. By Type
      • 16.1.2.2. By Product Type
      • 16.1.2.3. By Application
  • 16.2. Canada
    • 16.2.1. Pricing Analysis
    • 16.2.2. Market Share Analysis, 2023
      • 16.2.2.1. By Type
      • 16.2.2.2. By Product Type
      • 16.2.2.3. By Application
  • 16.3. Brazil
    • 16.3.1. Pricing Analysis
    • 16.3.2. Market Share Analysis, 2023
      • 16.3.2.1. By Type
      • 16.3.2.2. By Product Type
      • 16.3.2.3. By Application
  • 16.4. Mexico
    • 16.4.1. Pricing Analysis
    • 16.4.2. Market Share Analysis, 2023
      • 16.4.2.1. By Type
      • 16.4.2.2. By Product Type
      • 16.4.2.3. By Application
  • 16.5. Argentina
    • 16.5.1. Pricing Analysis
    • 16.5.2. Market Share Analysis, 2023
      • 16.5.2.1. By Type
      • 16.5.2.2. By Product Type
      • 16.5.2.3. By Application
  • 16.6. Germany
    • 16.6.1. Pricing Analysis
    • 16.6.2. Market Share Analysis, 2023
      • 16.6.2.1. By Type
      • 16.6.2.2. By Product Type
      • 16.6.2.3. By Application
  • 16.7. Italy
    • 16.7.1. Pricing Analysis
    • 16.7.2. Market Share Analysis, 2023
      • 16.7.2.1. By Type
      • 16.7.2.2. By Product Type
      • 16.7.2.3. By Application
  • 16.8. France
    • 16.8.1. Pricing Analysis
    • 16.8.2. Market Share Analysis, 2023
      • 16.8.2.1. By Type
      • 16.8.2.2. By Product Type
      • 16.8.2.3. By Application
  • 16.9. U.K.
    • 16.9.1. Pricing Analysis
    • 16.9.2. Market Share Analysis, 2023
      • 16.9.2.1. By Type
      • 16.9.2.2. By Product Type
      • 16.9.2.3. By Application
  • 16.10. Spain
    • 16.10.1. Pricing Analysis
    • 16.10.2. Market Share Analysis, 2023
      • 16.10.2.1. By Type
      • 16.10.2.2. By Product Type
      • 16.10.2.3. By Application
  • 16.11. Russia
    • 16.11.1. Pricing Analysis
    • 16.11.2. Market Share Analysis, 2023
      • 16.11.2.1. By Type
      • 16.11.2.2. By Product Type
      • 16.11.2.3. By Application
  • 16.12. BENELUX
    • 16.12.1. Pricing Analysis
    • 16.12.2. Market Share Analysis, 2023
      • 16.12.2.1. By Type
      • 16.12.2.2. By Product Type
      • 16.12.2.3. By Application
  • 16.13. China
    • 16.13.1. Pricing Analysis
    • 16.13.2. Market Share Analysis, 2023
      • 16.13.2.1. By Type
      • 16.13.2.2. By Product Type
      • 16.13.2.3. By Application
  • 16.14. Japan
    • 16.14.1. Pricing Analysis
    • 16.14.2. Market Share Analysis, 2023
      • 16.14.2.1. By Type
      • 16.14.2.2. By Product Type
      • 16.14.2.3. By Application
  • 16.15. South Korea
    • 16.15.1. Pricing Analysis
    • 16.15.2. Market Share Analysis, 2023
      • 16.15.2.1. By Type
      • 16.15.2.2. By Product Type
      • 16.15.2.3. By Application
  • 16.16. India
    • 16.16.1. Pricing Analysis
    • 16.16.2. Market Share Analysis, 2023
      • 16.16.2.1. By Type
      • 16.16.2.2. By Product Type
      • 16.16.2.3. By Application
  • 16.17. Thailand
    • 16.17.1. Pricing Analysis
    • 16.17.2. Market Share Analysis, 2023
      • 16.17.2.1. By Type
      • 16.17.2.2. By Product Type
      • 16.17.2.3. By Application
  • 16.18. Malaysia
    • 16.18.1. Pricing Analysis
    • 16.18.2. Market Share Analysis, 2023
      • 16.18.2.1. By Type
      • 16.18.2.2. By Product Type
      • 16.18.2.3. By Application
  • 16.19. Indonesia
    • 16.19.1. Pricing Analysis
    • 16.19.2. Market Share Analysis, 2023
      • 16.19.2.1. By Type
      • 16.19.2.2. By Product Type
      • 16.19.2.3. By Application
  • 16.20. Australia
    • 16.20.1. Pricing Analysis
    • 16.20.2. Market Share Analysis, 2023
      • 16.20.2.1. By Type
      • 16.20.2.2. By Product Type
      • 16.20.2.3. By Application
  • 16.21. New Zealand
    • 16.21.1. Pricing Analysis
    • 16.21.2. Market Share Analysis, 2023
      • 16.21.2.1. By Type
      • 16.21.2.2. By Product Type
      • 16.21.2.3. By Application
  • 16.22. GCC Countries
    • 16.22.1. Pricing Analysis
    • 16.22.2. Market Share Analysis, 2023
      • 16.22.2.1. By Type
      • 16.22.2.2. By Product Type
      • 16.22.2.3. By Application

17. Market Structure Analysis

  • 17.1. Competition Dashboard
  • 17.2. Competition Benchmarking
  • 17.3. Market Share Analysis of Top Players
    • 17.3.1. By Regional
    • 17.3.2. By Type
    • 17.3.3. By Product Type
    • 17.3.4. By Application

18. Competition Analysis

  • 18.1. Competition Deep Dive
    • 18.1.1. Abbott
      • 18.1.1.1. Overview
      • 18.1.1.2. Product Portfolio
      • 18.1.1.3. Profitability by Market Segments (Product/Age /Sales Channel/Region)
      • 18.1.1.4. Sales Footprint
      • 18.1.1.5. Strategy Overview
        • 18.1.1.5.1. Marketing Strategy
        • 18.1.1.5.2. Product Strategy
        • 18.1.1.5.3. Channel Strategy
    • 18.1.2. Thermo Fisher Scientific Inc.
      • 18.1.2.1. Overview
      • 18.1.2.2. Product Portfolio
      • 18.1.2.3. Profitability by Market Segments (Product/Age /Sales Channel/Region)
      • 18.1.2.4. Sales Footprint
      • 18.1.2.5. Strategy Overview
        • 18.1.2.5.1. Marketing Strategy
        • 18.1.2.5.2. Product Strategy
        • 18.1.2.5.3. Channel Strategy
    • 18.1.3. F. Hoffmann- La Roche Ltd.
      • 18.1.3.1. Overview
      • 18.1.3.2. Product Portfolio
      • 18.1.3.3. Profitability by Market Segments (Product/Age /Sales Channel/Region)
      • 18.1.3.4. Sales Footprint
      • 18.1.3.5. Strategy Overview
        • 18.1.3.5.1. Marketing Strategy
        • 18.1.3.5.2. Product Strategy
        • 18.1.3.5.3. Channel Strategy
    • 18.1.4. Bio-Rad Laboratories Inc.
      • 18.1.4.1. Overview
      • 18.1.4.2. Product Portfolio
      • 18.1.4.3. Profitability by Market Segments (Product/Age /Sales Channel/Region)
      • 18.1.4.4. Sales Footprint
      • 18.1.4.5. Strategy Overview
        • 18.1.4.5.1. Marketing Strategy
        • 18.1.4.5.2. Product Strategy
        • 18.1.4.5.3. Channel Strategy
    • 18.1.5. QIAGEN N.V.
      • 18.1.5.1. Overview
      • 18.1.5.2. Product Portfolio
      • 18.1.5.3. Profitability by Market Segments (Product/Age /Sales Channel/Region)
      • 18.1.5.4. Sales Footprint
      • 18.1.5.5. Strategy Overview
        • 18.1.5.5.1. Marketing Strategy
        • 18.1.5.5.2. Product Strategy
        • 18.1.5.5.3. Channel Strategy
    • 18.1.6. bioMerieux SA
      • 18.1.6.1. Overview
      • 18.1.6.2. Product Portfolio
      • 18.1.6.3. Profitability by Market Segments (Product/Age /Sales Channel/Region)
      • 18.1.6.4. Sales Footprint
      • 18.1.6.5. Strategy Overview
        • 18.1.6.5.1. Marketing Strategy
        • 18.1.6.5.2. Product Strategy
        • 18.1.6.5.3. Channel Strategy
    • 18.1.7. Standard BioTools Inc.
      • 18.1.7.1. Overview
      • 18.1.7.2. Product Portfolio
      • 18.1.7.3. Profitability by Market Segments (Product/Age /Sales Channel/Region)
      • 18.1.7.4. Sales Footprint
      • 18.1.7.5. Strategy Overview
        • 18.1.7.5.1. Marketing Strategy
        • 18.1.7.5.2. Product Strategy
        • 18.1.7.5.3. Channel Strategy
    • 18.1.8. Sysmex Inostics
      • 18.1.8.1. Overview
      • 18.1.8.2. Product Portfolio
      • 18.1.8.3. Profitability by Market Segments (Product/Age /Sales Channel/Region)
      • 18.1.8.4. Sales Footprint
      • 18.1.8.5. Strategy Overview
        • 18.1.8.5.1. Marketing Strategy
        • 18.1.8.5.2. Product Strategy
        • 18.1.8.5.3. Channel Strategy
    • 18.1.9. Eppendorf AG
      • 18.1.9.1. Overview
      • 18.1.9.2. Product Portfolio
      • 18.1.9.3. Profitability by Market Segments (Product/Age /Sales Channel/Region)
      • 18.1.9.4. Sales Footprint
      • 18.1.9.5. Strategy Overview
        • 18.1.9.5.1. Marketing Strategy
        • 18.1.9.5.2. Product Strategy
        • 18.1.9.5.3. Channel Strategy
    • 18.1.10. Danaher Corporation
      • 18.1.10.1. Overview
      • 18.1.10.2. Product Portfolio
      • 18.1.10.3. Profitability by Market Segments (Product/Age /Sales Channel/Region)
      • 18.1.10.4. Sales Footprint
      • 18.1.10.5. Strategy Overview
        • 18.1.10.5.1. Marketing Strategy
        • 18.1.10.5.2. Product Strategy
        • 18.1.10.5.3. Channel Strategy
    • 18.1.11. Cytiva
      • 18.1.11.1. Overview
      • 18.1.11.2. Product Portfolio
      • 18.1.11.3. Profitability by Market Segments (Product/Age /Sales Channel/Region)
      • 18.1.11.4. Sales Footprint
      • 18.1.11.5. Strategy Overview
        • 18.1.11.5.1. Marketing Strategy
        • 18.1.11.5.2. Product Strategy
        • 18.1.11.5.3. Channel Strategy
    • 18.1.12. Stilla Technologies
      • 18.1.12.1. Overview
      • 18.1.12.2. Product Portfolio
      • 18.1.12.3. Profitability by Market Segments (Product/Age /Sales Channel/Region)
      • 18.1.12.4. Sales Footprint
      • 18.1.12.5. Strategy Overview
        • 18.1.12.5.1. Marketing Strategy
        • 18.1.12.5.2. Product Strategy
        • 18.1.12.5.3. Channel Strategy
    • 18.1.13. Microsynth AG
      • 18.1.13.1. Overview
      • 18.1.13.2. Product Portfolio
      • 18.1.13.3. Profitability by Market Segments (Product/Age /Sales Channel/Region)
      • 18.1.13.4. Sales Footprint
      • 18.1.13.5. Strategy Overview
        • 18.1.13.5.1. Marketing Strategy
        • 18.1.13.5.2. Product Strategy
        • 18.1.13.5.3. Channel Strategy
    • 18.1.14. MatMaCorp
      • 18.1.14.1. Overview
      • 18.1.14.2. Product Portfolio
      • 18.1.14.3. Profitability by Market Segments (Product/Age /Sales Channel/Region)
      • 18.1.14.4. Sales Footprint
      • 18.1.14.5. Strategy Overview
        • 18.1.14.5.1. Marketing Strategy
        • 18.1.14.5.2. Product Strategy
        • 18.1.14.5.3. Channel Strategy
    • 18.1.15. JN Medsys
      • 18.1.15.1. Overview
      • 18.1.15.2. Product Portfolio
      • 18.1.15.3. Profitability by Market Segments (Product/Age /Sales Channel/Region)
      • 18.1.15.4. Sales Footprint
      • 18.1.15.5. Strategy Overview
        • 18.1.15.5.1. Marketing Strategy
        • 18.1.15.5.2. Product Strategy
        • 18.1.15.5.3. Channel Strategy
    • 18.1.16. PCR Biosystems
      • 18.1.16.1. Overview
      • 18.1.16.2. Product Portfolio
      • 18.1.16.3. Profitability by Market Segments (Product/Age /Sales Channel/Region)
      • 18.1.16.4. Sales Footprint
      • 18.1.16.5. Strategy Overview
        • 18.1.16.5.1. Marketing Strategy
        • 18.1.16.5.2. Product Strategy
        • 18.1.16.5.3. Channel Strategy

19. Assumptions & Acronyms Used

20. Research Methodology